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INTRODUCTION
Interferon-α (IFN-α) is a cytokine that has multi-
ple biological functions, including antiviral and
immunomodulatory activities (1), and is commonly
used for the treatment of patients with chronic hepa-
titis C virus (HCV) infection (2-6). The results of sever-
al recent clinical reports suggest that IFN-α treatment
is effective in decreasing serum alanine aminotransferase
levels (2-6), reducing and eliminating serum HCV
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RNA (4-6), and improving liver histology (2-4) in
patients with chronic hepatitis C. These conclusions
suggest that the role of IFN-α might be to elicit
antifibrogenic effects in the liver (3, 4). Its mode of
action (direct or indirect mechanism) on hepatic
fibrosis, however, is not entirely clear at present.
Hepatic fibrosis, or the deposition of the extracellular
matrix, is often associated with the hepatocellular
necrosis and inflammation that accompanies repair
processes (7), and is a consequence of liver dam-
age (8, 9). In the injured liver, hepatic stellate cells
(HSCs)(10, 11) in the space of Disse, which are
regarded as the primary target cells for inflamma-
tory stimuli (12), are transformed into α-smooth
muscle actin (α-SMA)-positive myofibroblast-like
cells, and are responsible for much of the collagen
hypersecretion and nodule formation that occurs
during hepatic fibrosis and cirrhosis (10, 11). It
should be noted that oxidative stress (13-15), in-
cluding oxygen-derived free radicals and lipid
peroxidation, is also implicated as a cause of hepat-
ic fibrosis. It has recently been demonstrated that
HSCs are activated by free radicals induced by Fe2+/
ascorbate, as well as by malondialdehyde (MDA)
(16), a product of lipid peroxidation, and that HSC
activation by type I collagen is blocked by antioxidants
(16).
In addition, histopathological studies of chronic
HCV infection have shown fatty changes in 31% to
72% of patients (17), indicating that hepatic steatosis
is a characteristic feature of chronic HCV infection.
It has been suggested that hepatic steatosis may
reflect a direct cytopathic effect of HCV and play a
role in the progression of the disease. In support of
these hypotheses, a transgenic mouse model ex-
pressing the HCV core gene, has been observed to
develop progressive hepatic steatosis (18). Hepatic
steatosis leads to an increase in lipid peroxidation,
which, in turn, activates HSCs, increases collagen
deposition (16), and, thus, induces hepatic fibro-
sis.
Many cells have their own enzymatic defense sys-
tems against oxidative stress, including superoxide
dismutase (SOD) and glutathione peroxidase (GPx)
(19, 20), which play a critical role in protecting the
cell from free radical damage, particularly lipid
peroxidation. Eukaryotic cells possess two main forms
of SOD : a predominantly cytosolic copper, zinc-dependent
SOD (CuZn-SOD) and a manganese-dependent SOD
(Mn-SOD) that is found in the mitochondrial matrix
(21). However, little is known about the antioxidative
role of IFN-α in the liver. Therefore, the effects of
IFN-α on rat hepatocytes undergoing oxidative stress
and HSCs in primary culture as well as isolated rat
mitochondria were examined in order to assess the
antioxidant activity of IFN-α.
MATERIALS AND METHODS
Hepatocyte Isolation and Induction of Oxidative
Stress.
Hepatocytes were isolated from the livers of male
Wistar rats (500～600g) as described elsewhere
(22). Inocula of 5×105 cells were introduced into
20-mm diameter plastic dishes. The cells were cul-
tured in 1 ml of Williams medium E (WE) supple-
mented with 5% fetal bovine serum (FBS), 100 U/ml
penicillin, 100 µg/ml streptomycin, and 1% L-glutamine
at 37℃ in a 5% CO2 atmosphere and 100% humid-
ity. After 4 h, the cell medium was removed, and
lipid peroxidation was induced in the hepatocytes
by incubation in serum-free WE with 100 µmol/l fer-
ric nitrilotriacetate solution (FeNTA) in the pres-
ence or absence of natural human IFN-α (OIF,
Otsuka Pharmaceutical Co., Osaka, Japan ; 0.5, 2,
5 and 20×103 U/ml) for 24 h. This system repre-
sents a well-established method for the induction
of lipid peroxidation both in vivo (23) and in vitro
(24). The eventual damage of cultured hepatocytes
in the presence of FeNTA was evaluated by measur-
ing lactate dehydrogenase (LDH) activity in the cul-
ture medium using a Hitachi model 7350 Autoanalyzer
(Hitachi, Tokyo, Japan).
Isolation and Cultivation of HSCs.
HSCs were isolated from the livers of male Wistar
rats (500～600 g) as described previously (22, 25).
Cells were plated at a density of 5×105 per well in
1 ml Dulbecco’s modified Eagle’s medium (DMEM)
on 20-mm diameter plastic dishes. The culture me-
dium was changed at 48-h intervals with DMEM
supplemented with 10% FBS in the presence or ab-
sence of IFN-α (OIF ; 0.5, 2, 5 and 20×103 U/ml),
and the cells were maintained for up to 10 days at
37℃ in a 5% CO2 atmosphere and 100% humidity.
For the immunohistochemical examination of
α-SMA, a marker of HSC activation, HSCs that were
initially cultured for 2 days were then maintained
in DMEM with 10% FBS in the presence or absence
of IFN-α for an additional 4 days. Cells were pro-
cessed for indirect immunohistochemical techniques
using monoclonal anti-α-SMA antibody (DAKO,
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Glostrup, Denmark ; diluted 1 : 50) as described
elsewhere (22, 25). The reaction products were
photographed using a differential interference con-
trast (DIC) microscope (Axioskop, Carl Zeiss,
Heidenheim, Germany). For the Western blot analy-
sis of α-SMA, α-SMA in HSCs cultured at a density
of 106 per well was detected immunologically, as
described previously (22, 25). Immunoreactive
bands were visualized with an ECL Western blot-
ting detection system (chemiluminescence) kit
(Amersham, Arlington Heights, IL) according to
the manufacturer’s recommended protocol, and
evaluated by densitometric analysis.
Fluorescence Measurement of Oxidative Burst.
Oxidative stress in hepatocytes and HSCs was
examined using a CellProbeTM fluorescence assay
kit (DCFH-Oxidative Burst ; Coulter, Miami, FL).
The conversion of nonfluorescent dichlorofluorescein
diacetate (DCFH-DA) to the highly fluorescent com-
pound, 2’, 7’-dichlorofluorescein (DCF) can be used
to monitor the oxidative burst (26). The fluores-
cence of DCF is a measure of the production of
H2O2 and the presence of peroxidase. CellProbeTM
DCFH-Oxidative Burst contains DCFH-DA as a
substrate. To this end, cells were incubated in
Lab-Tek Chamber 8-well slides (Nunc, Naperville,
IL) with nonfluorescent DCFH-DA for 10 min, which
was subsequently converted to the fluorescent DCF
by subjecting it to oxidative stress. After washing,
the cells were fixed with 4% paraformaldehyde for
2 h at room temperature, and the DCF fluorescence
was observed by laser-scanning confocal fluores-
cence microscopy (TCS-4D, Leica, Heidelberg,
Germany). A multiple-line argon-ion laser beam was
used for single fluorescein emission after excitation
at 488 nm with a filter for fluorescein.
Antioxidant Enzyme Assays.
Hepatocytes or HSCs cultured at a density of 5×105
per well were washed twice with ice-cold phosphate-buffered
saline, lysed directly in 150 µl of 50 mmol/l Tris-HCl
(pH 7.5), 5 mmol/l ethylenediaminetetraacetic acid, and
1 mmol/l dithiothreitol, and disrupted by freeze-thawing
and sonication (Sonic Disseminator 50 ; Fisher Scien-
tific, Pittsburgh, PA) for 15 s at 50% energy output,
at 4℃. The suspension was then centrifuged at 14,000 g
at 4℃ for 30 min. The samples of the supernatants
were analyzed for antioxidant enzyme assays. Pro-
tein levels of CuZn-SOD and Mn-SOD were detect-
ed using enzyme-linked immunosorbent assay (ELISA)
system kits (Amersham, Little Chalfont, UK)(27, 28),
and were expressed as nanograms of immunoreactive
protein levels per milligram of protein. GPx activ-
ity was determined using a Cellular Glutathione
Peroxidase Assay kit (Calbiochem, San Diego, CA)
with the spectrophotometric method of Lawrence
and Burk (29), and were expressed as units per milli-
gram of protein. Enzyme assays were performed
according to each manufacturer’s protocol. Protein
concentrations were determined by the Lowry meth-
od (30) using bovine serum albumin as a standard.
Lipid Peroxidation.
For the determination of MDA levels in hepatocytes
and HSCs, the cells were washed with phosphate-buffered
saline followed by harvesting with a rubber police-
man, and were used in the analysis involving the
thiobarbiturate method as described previously (22).
Preparation of Liver Mitochondria.
Liver mitochondria were prepared from 250-300 g
male Wistar rats (31). Lipid peroxidation in isolated
rat liver mitochondria (0.7 mg/ml) after freezing
overnight and thawing the next day was measured
by monitoring oxygen consumption at 25℃ with a
Clark-type oxygen electrode on the assumption that
the saturated oxygen concentration at 25℃ is 258
µmol/l, in the presence of 100 mmol/l of iron (II)
sulfate heptahydrate (FeSO4) and 1 mmol/l adenine
diphosphate with or without IFN-α (0.5, 2, 5, 10, and
20 × 103 U/ml) in a total volume of 2.53 ml of 10 mmol/l
Tris-HCl (pH 7.5) and 175 mmol/l KCl. The inhibi-
tion rate (%) of IFN-α against lipid peroxidation was
calculated based on the amount of consumed oxy-
gen as described by Pan and Hori (32).
Statistical Analysis.
Data are presented as means ± SD unless other-
wise indicated. The means were compared between
two groups using Wilcoxon’s signed-rank test and
the Mann-Whitney U test. All p values are two-tailed.
A p value of less than 0.05 was considered to be
statistically significant.
RESULTS
Effects of IFN-α on Lipid Peroxidation and Antioxidant
Enzyme Levels in Cultured Rat Hepatocytes Undergoing
Oxidative Stress.
Increased levels of extracellular LDH (489 ± 81
U/ml) and intracellular MDA (3.12 ± 0.56 nmol/
well) were observed in hepatocytes incubated with
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100 µmol/l FeNTA for 24 h compared to controls
(65 ± 12 U/ml, 0.68 ± 0.18 nmol/well, respective-
ly) (left panel in Fig. 1). However, the FeNTA en-
hancement of lipid peroxidation in the cultures was
significantly inhibited by IFN-α in a dose-dependent
manner (0.5-20×103 U/ml) (Fig. 1). Furthermore,
ELISA analyses of enzyme activities in the cells
revealed that oxidative stress significantly attenuated
protein levels of CuZn-SOD (2.8 ± 0.5 ng/mg pro-
tein) and Mn-SOD (1.2 ± 0.3 ng/mg protein) and
GPx activities (5.2 ± 0.9 U/mg protein) compared
to the controls (8.5 ± 1.7 ng/mg protein, 2.4 ± 0.6
ng/mg protein, 7.1 ± 1.5 U/mg protein, respec-
tively), while IFN-α induced their activities in a
dose-dependent manner (0.5-20×103 U/ml) (right
panel in Fig. 1).
When the effect of IFN-α on hepatocyte oxidative
bursts was examined using the fluorescence probe
DCF in conjunction with laser-scanning confocal
microscopic techniques, the DCF fluorescence gen-
erated via oxidative stress in hepatocytes for 24 h
of IFN-α-supplemented culture was found to be
dose-dependently attenuated (Fig. 2). These findings
suggest that IFN-α functions as an antioxidant in
hepatocytes.
Effects of IFN-α on Oxidative Stress and Antioxidant
Enzyme Levels in Isolated Rat HSCs.
When isolated HSCs were cultured on uncoated plas-
tic dishes in DMEM supplemented with 10% FBS,
they underwent transformation within 5 days to
myofibroblast-like cells with enlarged cell bodies contain-
Fig. 1. Effects of IFN-α on intracellular
MDA ( ) and extracellular LDH ( )
levels (left panel) and antioxidant enzyme
[CuZn-SOD (■), Mn-SOD (□), and GPx
( ) ]levels (right panel) in cultured rat
hepatocytes undergoing oxidative stress.
Cells were cultured in WE supplemented
with 5% FBS for 4 h and then incubated
with 100 µmol/l FeNTA (Oxidative stress)
in the presence or absence of IFN-α
(0.5～20×103 U/ml) for 24 h. Values
are means ± SD for 5 dishes. ＊P<0.05
compared to cultures incubated with
FeNTA in the absence of IFN-α.
Fig. 2. Effects of IFN-α on oxidative bursts in hepatocytes us-
ing the fluorescence probe DCF and laser scanning confocal
microscopic techniques. Cells were cultured in WE supplemented
with 5% FBS for 4 h and then incubated with 100 µmol/l FeNTA
(Oxidative stress) in the presence or absence of IFN-α for 24 h.
(A) Oxidative stress ; (B) 2×103 U/ml IFN-α ; (C)5×103 U/ml
IFN-α ; (D)20×103 U/ml IFN-α. Nonfluorescent DCFH-DA sup-
plementation for 10 min resulted in its conversion to fluores-
cent DCF through the action of H2O2 and peroxidase. The micro-
graphs show typical results of three independent experiments.
Original magnification ×200.
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ing fewer lipid particles and exhibiting immunoreactive
α-SMA. Six days after cell plating, most of the cells
spread well and showed α-SMA-positive microfilaments
(Fig. 3A). Supplementation of the medium with
IFN-α (20×103 U/ml), however, inhibited both cell
spreading and staining with the antibody to α-SMA
(Fig. 3B) and induced the formation of numerous
lipid droplets in the cytoplasmic space compared
with the control cell culture (data not shown). West-
ern blotting experiments also resulted in a reduc-
tion in α-SMA expression that was dependent on
IFN-α concentration (Fig. 4).
In addition, the production of MDA in cultured
HSCs was dose-dependently inhibited by IFN-α (left
panel in Fig. 5). We assayed the effects of IFN-α
on antioxidant enzyme levels in cultured HSCs. IFN-α
was found to increase CuZn-SOD and Mn-SOD pro-
tein levels in a dose-dependent manner (right pan-
el in Fig. 5), although GPx activities were not de-
tectable, but under the lower detection limits for our
GPx assay system that corresponds to approximate-
ly 5.6 mU/ml.
Moreover, a dose-dependent attenuation of DCF
fluorescence was observed (Fig. 6). The DCF fluo-
rescence, which was generated via oxidative stress,
increased in HSC bodies in the IFN-α-unsupplemented
culture (data not shown). These findings suggest
that IFN-α plays an inhibitory role in processes that
are mediated by oxidative bursts in HSCs.
Effects of IFN-α on Lipid Peroxidation in Isolated
Rat Liver Mitochondria.
The addition of adenine diphosphate and Fe2+ to
a suspension of rat liver mitochondria induced a
Fig. 3. Reaction of cultured rat HSCs with an antibody to α-SMA.
Cells were cultured in DMEM supplemented with 10% FBS for
2 days and then incubated in the absence (A) or presence of
IFN-α at a dose of 20×103 U/ml (B) for 4 days, immunologically
stained for α-SMA, and then photographed using a differential
interference contrast microscope. The micrographs represent
the typical results of three independent experiments. Original
magnification ×300.
Fig. 4. (A) Effect of IFN-α on α-SMA expression in cultured rat
HSCs. Cells cultured in DMEM supplemented with 10% FBS for
2 days were incubated in the presence or absence of IFN-α (0.5～
20×103 U/ml) for 8 days. Cell lysates were subjected to 12% so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis and
transferred onto nylon membranes, and α-SMA was detected
immunologically. The graphs represent the typical results of
four independent experiments. (B) Densitometric analysis of
α-SMA expression in cultured rat HSCs induced in the pres-
ence of IFN-α (0.5～20×103 U/ml) shown in (A). The results of
the densitometric analysis are expressed as mean percentages
(± SD) of the control values (n=5). ＊P<0.05 compared with con-
trols.
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lower oxygen consumption for about 2 min, after
which consumption became more rapid until near-
ly all the oxygen in the incubation medium had
been consumed (data not shown). The amount of
MDA formed from the oxidized fatty acid chains of
mitochondrial phospholipids was well correlated with
the extent of oxygen consumption at this stage (data
not shown). IFN-α (0.5-20×103 U/ml) caused a
dose-dependent inhibition of oxygen uptake in the
second stage after the lag time (data not shown),
indicating that IFN-α inhibits lipid peroxidation in
rat liver mitochondria. From the dose-response plots
of the antiperoxidative effect of IFN-α, the concen-
tration of IFN-α required for the 50% inhibition of
lipid peroxidation was determined to be 12×103 U/ml
(Fig. 7).
DISCUSSION
There is evidence that free radicals cause tissue
injury by initiating lipid peroxidation and inducing
irreversible modifications of cell membrane struc-
ture and function (33, 34), and that the products of
lipid peroxidation modulate collagen gene expres-
sion in the liver (13). This evidence suggests that
lipid peroxidation may be a link between liver in-
jury and hepatic fibrosis (35). Although it is diffi-
cult to discriminate between the profibrogenic effect
of the necrotic event and the true fibrogenic effect
induced by free radical species, an independent stimu-
lation of extracellular matrix deposition, including
collagens, appears to occur at a prenecrotic stage
during oxidative stress-associated liver injury (35).
Recently, it has been reported that paracrine stimuli
derived from hepatocytes undergoing oxidative stress
induce HSC proliferation and collagen synthesis (36).
Further, it has been shown that HSCs are activated
by the generation of free radicals and by MDA(16)
and 4-hydroxynonenal (13), aldehydic products of
lipid peroxidation, and antioxidants have been ob-
served to inhibit HSC activation by type I collagen
(16).
Fig. 5. Effects of IFN-α on MDA ( )
levels (left panel) and antioxidant enzyme
[CuZn-SOD (■) and Mn-SOD (□)] levels
(right panel) in cultured rat HSCs. Cells
were cultured in DMEM supplemented
with 10% FBS for 2 days and then in the
presence or absence of IFN-α (0.5～20×
103 U/ml) for an additional 8 days. Val-
ues are means ± SD for 5 dishes. ＊P<0.05
compared with controls.
Fig. 6. Effects of IFN-α on oxidative bursts in HSCs using the
fluorescence probe DCF and a laser-scanning confocal micro-
scopic technique. Cells, cultured in DMEM supplemented with
10% FBS for 4 days, were incubated in the presence or absence
of IFN-α for 24 h. (A) Control ; (B) 2×103 U/ml IFN-α ; (C)
5×103 U/ml IFN-α ; (D) 20×103 U/ml IFN-α. Nonfluorescent
DCFH-DA supplementation for 10 min resulted in the conver-
sion of DCFH-DA into fluorescent DCF through the action of
H2O2 and peroxidase. The micrographs represent the typical
results of three independent experiments. Original magnifica-
tion ×300.
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We have shown here that IFN-α inhibits the
prooxidant (FeNTA)-enhanced lipid peroxidation and
oxidative burst in cultured rat hepatocytes, and sup-
presses the α-SMA expression and oxidative burst
as well as MDA production during the activation of
isolated rat HSCs cultured on uncoated plastic dishes. In
addition, IFN-α was observed to inhibit lipid peroxidation
in rat liver mitochondrial membranes. These results
are in agreement with a report that IFN-α inhibits
collagen synthesis, α-SMA expression, and prolifera-
tion in cultured human HSCs (37). Therefore, IFN-α
may exert its direct and fibrosuppressive effects in
the liver, at least in part, through its antioxidant
activity.
Despite the multiplicity of antioxidant defense
mechanisms, the generation of lipid peroxidation
during the course of hepatofibrogenesis may exceed
the capacity of antioxidant defense mechanisms
and contribute to the development of liver injury.
In this study, the two variables of hepatic levels of
antioxidant defense enzymes, CuZn-SOD, Mn-SOD,
and GPx, and a product of oxidative stress, MDA,
were reciprocal ; hepatocytes undergoing oxidative
stress and HSCs undergoing activation had signifi-
cantly lower antioxidant enzyme levels and higher
lipid peroxidation product levels. Very recently,
Whalen et al . have also reported that the activation of
rat HSCs leads to a loss of glutathione S-transferases,
which detoxify lipid peroxidation products (38). These
findings suggest that enzymatic defense systems may
be impaired in hepatic fibrosis. In the present study,
however, IFN-α was found to dose-dependently in-
crease the immunoreactive protein levels of CuZn-SOD
and Mn-SOD as well as the enzyme activities of GPx,
and to decrease the MDA levels in oxidatively stressed
hepatocytes and activated HSCs, although GPx ac-
tivities were not detected in the latter cells with or
without IFN-α supplementation. Lalazar et al . have
reported the early gene expression of GPx during
HSC activation in a rat model of hepatic fibrosis
(39). It should be pointed out that immunoreactive
protein and enzyme activity changes are not nec-
essarily related to changes in mRNA levels in many
instances (40), and that differences might exist in
the cellular defense mechanisms against oxidative
stress under different conditions and cell types (40,
41). At any rate, it appears that IFN-α can enhance
biological defense activities against oxidative stress
in the liver.
After administration of a single therapeutic dose
of IFNs, the peak peripheral plasma levels have been
reported to anywhere from 40 to 150 U/ml (42, 43).
However, there is evidence for drug accumulation
by a factor of 2 to 5 after repeated administration (44).
Our results showed that the lowest effective IFN-α
concentration in cultured hepatocytes and HSCs is
2×103 U/ml, although the concentration required
for 50% inhibition of lipid peroxidation in isolated
liver mitochondria was 12×103 U/ml. These results
suggest that this may be the lowest concentration
at which IFN-α is capable of exerting antioxidative
effects in vivo .
When hepatocytes are continuously damaged and
replicated, the frequencies of genetic alterations also
probably increase along with hepatic fibrosis, lead-
ing to the development of HCC and cirrhosis. It is
generally accepted that multiple genetic alterations,
which are induced by mutations, are important in
carcinogenesis. Several reports have suggested that
the IFN-α treatment of patients with chronic HCV infec-
tion may lower their risk of developing hepatocellular
carcinoma (45, 46), and that IFN-α expresses potent
antitumor effects both by exerting direct antiproliferative
effects on target tumor cells and by activating host
cytotoxic effector cells to more efficiently lyse tar-
get tumor cells (1). Thus, our findings, which show
that IFN-α plays a role as a direct antioxidant and
defensive enzyme-stimulant in damaged hepatocytes
and activated HSCs, suggests that IFN-α may have
beneficial effects, not only on hepatic fibrosis, but
also on hepatocellular carcinoma development in pa-
tients with chronic hepatitis C.
Fig. 7. Inhibition of IFN-α on lipid peroxidation in freeze -thawed
rat liver mitochondria induced by Fe2+ and adenosine diphosphate.
Values are means ± SD for five independent experiments. The
calculation method was described in the Materials and Meth-
ods.
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